Location History:
- Liaoning, CN (2009)
- Shenyang, CN (2015 - 2021)
Company Filing History:
Years Active: 2009-2021
Title: Yanfeng Liu: Innovator in Cancer Treatment and Analgesic Peptides
Introduction
Yanfeng Liu is a prominent inventor based in Shenyang, China. He has made significant contributions to the fields of cancer treatment and analgesic drug development. With a total of three patents to his name, Liu's work focuses on innovative solutions that address critical health challenges.
Latest Patents
Liu's latest patents include groundbreaking research on the VGSC β3 protein. This invention relates to inhibitors of the VGSC β3 protein, which can be utilized for the prevention, treatment, and diagnostic detection of cancers. The application outlines methods for using the VGSC β3 protein or its inhibitors to diagnose, prevent, and treat cancer, as well as to screen antineoplastic agents. Another notable patent is for the analgesic active peptide VGG, which is derived from scorpions. This invention details the preparation and use of the active peptide, including its extraction, separation, and purification. The peptide is designed for use in analgesic drug formulations, which can be administered through various methods, including injection and oral administration.
Career Highlights
Yanfeng Liu is affiliated with Shenyang Pharmaceutical University, where he continues to advance his research and innovation in pharmaceuticals. His work has garnered attention for its potential impact on cancer treatment and pain management.
Collaborations
Liu collaborates with notable colleagues, including Jinghai Zhang and Chunfu Wu, who contribute to his research endeavors.
Conclusion
Yanfeng Liu's innovative work in the development of cancer treatment methods and analgesic peptides highlights his significant role in advancing medical science. His contributions are paving the way for new therapeutic options that could benefit many patients in need.